| ABPM |
ambulatory blood pressure monitoring |
| ACC |
American College of Cardiology |
| ACE |
angiotensin-converting enzyme |
| ACLS |
advanced cardiac life support |
| ACS |
acute coronary syndromes |
| ADA |
American Diabetes Association |
| AEDs |
automatic external defibrillators |
| AGEs |
advanced glycation end-products |
| AHA |
American Heart Association |
| AI |
adequate intake |
| ALE |
advanced lipoxidation end products |
| AMDRs |
Acceptable Macronutrient Distribution Ranges |
| AOPP |
advanced oxidation protein products |
| apo(a) |
apolipoprotein(a) |
| ApoE |
Apolipoprotein E |
| ARBs |
angiotensin-receptor blockers |
| ASA |
acetylsalicylic acid |
| ASCVD |
atherosclerotic cardiovascular disease |
| BDI |
Beck Depression Inventory |
| BIA |
bioimpedance |
| BMI |
body mass index |
| CAB |
coronary artery bypass |
| CAD |
coronary artery disease |
| CAPD |
continuous ambulatory peritoneal dialysis |
| CBS |
cystathionine synthase |
| CBV |
central blood volume |
| CBVD |
cerebrovascular disease |
| CCB |
calcium-channel blockers |
| CHF |
congestive heart failure |
| CKD |
chronic kidney disease |
| CMS |
Centers for Medicare and Medicaid Services |
| CRP |
C-reactive protein |
| CT |
cardiothoracic |
| CVD |
cardiovascular disease |
| DCCT |
Diabetes Control and Complications Trial |
| DEXA |
dual energy X-ray absorptiometry |
| DHA |
docosahexenoic acid |
| EBCT |
electron-beam computerized tomography |
| ECG |
electrocardiogram |
| EMS |
Emergency Medical Services |
| EPA |
eicosapentaenoic acid |
| FSH |
follicle-stimulating hormone |
| GI |
gastrointestinal |
| GnRH |
gonadotropin-releasing hormone |
| HD |
hemodialysis |
| HGS |
handgrip strength |
| HHCY |
hyperhomocysteinemia |
| HRT |
hormone replacement therapy |
| hs-CRP |
high-sensitive C-reactive protein |
| IDH |
intradialytic hypotension |
| IHD |
ischemic heart disease |
| IL-6 |
interleukin-6 |
| IOM |
Institute of Medicine |
| IVC |
inferior vena cava |
| JNC |
Joint National Committee for the Prevention, Detection, Evaluation and Treatment of High Blood Pressure |
| LDLs |
low-density lipoproteins |
| LH |
leutinizing hormone |
| Lp(a) |
lipoprotein(a) |
| LNA |
alpha-linolenic acid |
| LV |
left ventricular |
| LVH |
left ventricular hypertrophy |
| MAP |
mean arterial pressure |
| MDA |
malondialdehyde |
| MI |
myocardial infarction |
| MMPI |
Minnesota Multiphasic Personality Inventory |
| MPO |
myeloperoxidase |
| MRA |
magnetic resonance angiography |
| MRI |
magnetic resonance imaging |
| MS |
methionine synthase |
| MTHFR |
5,10-methylene tetrahydrofolate reductase |
| nPCR |
normalized protein catabolic rate |
| PCI |
percutaneous coronary intervention |
| PD |
peritoneal dialysis |
| PEM |
protein-energy malnutrition |
| PP |
pulse pressure |
| PTH |
parathyroid hormone |
| PUFAs |
polyunsaturated fatty acid |
| PVD |
peripheral vascular disease |
| PVR |
peripheral vascular resistance |
| PWV |
pulse wave velocity |
| RDA |
Recommended Dietary Allowance |
| rhEPO |
recombinant human erythropoietin |
| RRT |
renal replacement therapy |
| SCD |
sudden cardiac death |
| SGA |
subjective global assessment |
| STAI |
State-Trait Anxiety Inventory |
| STAXI |
State-Trait Anger Expression Scale |
| SVAs |
supraventricular arrhythmias |
| TIA |
transient ischemic attack |
| UKPDS |
United Kingdom Prospective Diabetes Study |
| USRDS |
United States Renal Data System |
| VF |
ventricular fibrillation |
| VHD |
valvular heart disease |
| VT |
ventricular tachycardia |
| WHI |
Women’s Health Initative |